Julie DiMauro35 min listen
GRIP2 min read
Vlada Gurvich3 min read

The GRIP team looks at the prospects for the ESG agenda in 2026.
GRIP4 min read

The GRIP team assesses cybersecurity and the threat landscape for 2026.
GRIP3 min read

Mirko also touched on public company and crypto matters, saying the agencies will still focus on investor harm but emphasize useful disclosure, welcoming innovation and bolstering the private markets.
Julie DiMauro4 min read

Continuing our series of articles anticipating 2026, GRIP writers share their thoughts on regulatory prospects.
GRIP3 min read

Some industry insiders weigh in on what we can expect for the coming year.
Carmen Cracknell2 min read

Principal third-party disclosure mechanisms and the common pitfalls for pharmaceutical compliance and risk teams.

In many ways, 2025 found the healthcare sector at a crossroads, with compliance officers holding their heads.
Kevin Kinsella4 min read

Duncan Hennes, managing director in the KPMG Financial Services Risk, Regulatory, and Compliance Advisory practice, tells us about the ever-growing prediction marketplace.
Julie DiMauro35 min listen